Sue Gail Eckhardt

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Nina Ayer, Attorney in Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sue Gail Eckhardt:

Stock Role Class Num Shares Value Price $ Report Date Ownership
EXELIXIS, INC. Director Common Stock 21.4K $934K $43.67 02 Jun 2025 Direct
Syros Pharmaceuticals, Inc. Director Common Stock 16K $79.2K $4.95 05 Jun 2024 Direct
EXELIXIS, INC. Director Option (right to buy) 23.1K 14 Feb 2025 Direct
Syros Pharmaceuticals, Inc. Director Stock Option (right to buy) 6K 05 Jun 2024 Direct

Insider Reports Filed by Sue Gail Eckhardt

Symbol Company Period Transactions Value $ Form Type Role Filing Time
EXEL EXELIXIS, INC. 02 Jun 2025 2 -$805K 4 Director 04 Jun 2025, 19:57
EXEL EXELIXIS, INC. 29 May 2025 1 $0 4 Director 30 May 2025, 19:12
EXEL EXELIXIS, INC. 14 Feb 2025 4 -$226K 4 Director 19 Feb 2025, 20:31
SYRS Syros Pharmaceuticals, Inc. 05 Jun 2024 2 $0 4 Director 07 Jun 2024, 16:30
EXEL EXELIXIS, INC. 31 May 2024 1 $0 4 Director 04 Jun 2024, 20:19
EXEL EXELIXIS, INC. 05 Jan 2024 2 $0 4 Director 09 Jan 2024, 21:08
EXEL EXELIXIS, INC. 05 Jan 2024 0 $0 3 Director 09 Jan 2024, 21:03
SYRS Syros Pharmaceuticals, Inc. 01 Jun 2023 2 $0 4 Director 02 Jun 2023, 16:24
SYRS Syros Pharmaceuticals, Inc. 16 Sep 2022 2 $0 4 Director 19 Sep 2022, 17:09
SYRS Syros Pharmaceuticals, Inc. 01 Jun 2022 1 $0 4 Director 02 Jun 2022, 19:07
SYRS Syros Pharmaceuticals, Inc. 08 Jun 2021 1 $0 4 Director 10 Jun 2021, 17:27